Retatrutide (LY3437943, developed by Eli Lilly) is a triple hormone receptor agonist, activating GLP-1, GIP, and glucagon receptors simultaneously
Meet the Experts Hadley King, MD, a board-certified dermatologist based in New York City
Its only natural, but when your awareness of healthy habits should be at its highest, alcohol can easily cloud your judgment and steer you off course
Should I skip my GLP-1 shot if I have the flu
If benefit may change over time, follow-up matters
Why Some People Become Dehydrated While Taking Ozempic The physiological pathways leading to a negative fluid balance on semaglutide are typically multi-factorial, stemming from a combination of digestive distress and behavioral shifts